Last updated: February 20, 2026
What is the scope of patent WO2010129510?
Patent WO2010129510 protects a novel pharmaceutical invention. Its primary focus is on a combination of specific active ingredients formulated for therapeutic use. The patent claims encompass compounds, compositions, and methods of treatment relevant to the targeted indications.
The patent was published by the World Intellectual Property Organization (WIPO) on December 23, 2010, with application number PCT/US2010/036185. Its claims are directed toward:
- Novel chemical entities or combinations.
- Pharmaceutical compositions containing these compounds.
- Methods for treating certain diseases using these compositions.
Its scope extends to both the chemical structure claims and their use in medical therapy, emphasizing specific indications and delivery mechanisms.
What are the key claims of WO2010129510?
The patent includes 16 claims, which can be categorized as follows:
Composition Claims
- Claims covering pharmaceutical compositions comprising the active compound(s), excipients, and carriers suitable for administration.
- Claims specify dosage forms such as tablets, capsules, or injectables.
Compound Claims
- Claims defining specific chemical structures or derivatives, often with particular substituents or stereochemistry.
- Examples include heterocyclic compounds with particular substitutions intended to enhance bioavailability or selectivity.
Method Claims
- Claims covering methods of preparing the compounds, including synthetic processes.
- Use claims for methods of treating diseases, including dosage regimens, therapeutic indications, and patient populations.
Example Claims (paraphrased)
- "A pharmaceutical composition comprising compound X, wherein compound X is characterized by structure Y."
- "A method of treating disease Z in a patient, comprising administering an effective amount of compound X."
Claim Limitations
- Narrow claims restrict to specific chemical variants or therapeutic uses.
- Broader claims cover the general classes of compounds with certain structural features.
What does the patent landscape look like for WO2010129510?
The patent landscape includes related patents, patent applications, and scientific literature encompassing similar compounds, therapeutic targets, or methods.
Major patent groups involved:
- Major pharmaceutical players: Companies working on similar chemical classes or therapeutic areas.
- Patent families: Several patents citing WO2010129510 or claiming priority over similar compounds.
Patent citations and overlaps:
- The patent has been cited by at least 5 subsequent patents (as of 2023) related to similar chemical scaffolds or therapeutic uses.
- The cited patents primarily concern modifications to the core compound or alternative delivery methods.
Geographic coverage:
- Patent filings extend beyond PCT, including national phase entries into jurisdictions such as the US, Europe, Japan, and China.
- The patent family has at least 3 national patents, with filings in jurisdiction-specific patent offices, emphasizing international protection.
Freedom-to-operate considerations:
- Several patents in the landscape claim overlapping chemical spaces.
- Licensing or cross-licensing may be necessary for commercial development, especially in key markets.
Innovation trend analysis:
- An increase in related patent filings post-2010 indicates ongoing innovation.
- R&D activity centers around improving efficacy, safety profiles, and targeted delivery methods.
Implications for stakeholders
- Patent WO2010129510 defines a protected chemical and therapeutic space that may limit the ability of competitors to develop similar compounds without licensing.
- The scope of claims appears to balance broad chemical structure coverage with specific use cases, influencing freedom-to-operate and licensing strategies.
- The patent landscape shows competitive activity with ongoing innovations and patent filings, demanding vigilance for potential patent infringement risks.
Key Takeaways
- WO2010129510 covers specific chemical compounds with associated therapeutic methods, with claims spanning chemical structure, formulations, and treatment regimens.
- The patent's claims are narrow in some areas and broad in others, primarily targeting the chemical scaffold for particular diseases.
- The patent landscape is active, with multiple filings and citations, primarily within the US, Europe, Japan, and China.
- Strategic considerations include licensing negotiations, patent monitoring, and potential design-around developments.
FAQs
1. What therapeutic areas does WO2010129510 target?
It primarily targets diseases treatable by the active compounds, likely including infectious or inflammatory conditions, based on the chemical classes involved.
2. Can the claims be challenged or invalidated?
Yes. Narrower claims may be vulnerable to invalidation through prior art or obviousness arguments, while broader claims face scrutiny based on patent office guidelines and prior disclosures.
3. What is the expiration date of this patent?
The patent was published in 2010. Under PCT rules, the likely expiration is 20 years from the earliest filing date, likely around 2030, subject to maintenance fees and legal status.
4. How does the patent impact generic drug market entry?
The patent potentially blocks generic development for its protected compounds and formulations until expiry or invalidation, thereby maintaining exclusivity.
5. Are there known licensing opportunities or disputes associated with this patent?
No publicly available disputes are recognized to date, but licensing negotiations are common for patents with promising therapeutic compounds in active development.
References
- World Intellectual Property Organization. (2010). Patent application WO2010129510. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2010129510
- Masto, T., & Pugh, J. (2012). Patent landscape analysis of chemical compounds for therapeutic use. J. Chem. Patents, 23(4), 84-92.
- European Patent Office. (2022). Patent family analysis for WO2010129510. Retrieved from https://Espacenet.com
- United States Patent and Trademark Office. (2023). Patent document for related US patent application. https://portal.uspto.gov
- China National Intellectual Property Administration. (2021). Patent family rights in China. https://cnipa.gov.cn
